at://
/
app.bsky.feed.post
/
3mnrj3cpiec2a
sign in
All
4
Record
2
Post
1
PostEmbed
1
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
Survodutide, a dual GLP-1/glucagon agonist grabbed the spotlight at #ADASciSessions yesterday with evidence that it has metabolic benefits in obesity beyond weight loss. conscienhealth.org/2026/06/08/a...
4d
